StonvexLoading…
StonvexStonvexStonvexCore line items from PHG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €17.83B | €18.02B | €18.17B | €17.83B |
Operating Income | €1.42B | €529.00M | €-115.00M | €-1.53B |
Net Income | €897.00M | €-698.00M | €-463.00M | €-1.60B |
EPS (Diluted) | €0.93 | €-0.75 | €-0.49 | €-1.69 |
Total Assets | €26.94B | €28.98B | €29.41B | €30.69B |
Total Liabilities | €15.95B | €16.93B | €17.34B | Not available |
Cash & Equivalents | €2.79B | €2.40B | €1.87B | €1.17B |
Free Cash Flow OCF − CapEx | €903.00M | €1.25B | €1.79B | €-617.00M |
Shares Outstanding | Not available | Not available | 39.33M | 14.17M |